The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. DarioHealth Corp shares valued at $4,546 were purchased by Nelson Steven Charles on Nov 12 ’24. At $0.91 per share, Nelson Steven Charles acquired 5,000 shares. The insider’s holdings grew to 55,000 shares worth approximately $40700.0 following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, Nelson Steven Charles purchased 5,000 shares, netting a total of over 4,221 in proceeds. Following the buying of shares at $0.84 each, the insider now holds 45,000 shares.
Before that, Nelson Steven Charles had added 5,000 shares to its account. In a trade valued at $4,022, the Chief Commercial Officer bought DarioHealth Corp shares for $0.80 each. Upon closing the transaction, the insider’s holdings increased to 5,000 shares, worth approximately $37000.0.
As published in a research note from Alliance Global Partners on May 13, 2022, DarioHealth Corp [DRIO] has been rated up from a Neutral to a Buy and the price target has been revised to $8.75. Analysts at Cowen started covering the stock with ‘”an Outperform”‘ outlook in a report released in late April. As of March 23, 2021, Stifel has initiated its “Buy” rating for DRIO. Earlier on February 25, 2021, Cantor Fitzgerald initiated its rating. Their recommendation was “an Overweight” for DRIO stock.
Analyzing DRIO Stock Performance
During the last five days, there has been a drop of approximately -1.32%. Over the course of the year, DarioHealth Corp shares have dropped approximately -56.97%. Shares of the company reached a 52-week high of $2.6000 on 02/15/24 and a 52-week low of $0.6500 on 12/18/24. A 50-day SMA is recorded $0.8568, while a 200-day SMA reached $1.1453. Nevertheless, trading volume fell to 0.6 million shares from 0.17 million shares the previous day.
Support And Resistance Levels for DarioHealth Corp (DRIO)
According to the 24-hour chart, there is a support level at 0.6789, which, if violated, would cause prices to drop to 0.6178. In the upper region, resistance lies at 0.7923. The next price resistance is at 0.8446. RSI (Relative Strength Index) is 46.96 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.0330, which suggests the price will decrease in the coming days. Percent R is at 39.93%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.
